Resources Management Corp’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18K | Sell |
220
-278
| -56% | -$22.7K | ﹤0.01% | 322 |
|
|
2025
Q1 | $40K | Sell |
498
-95
| -16% | -$7.63K | 0.01% | 289 |
|
|
2024
Q4 | $53K | Hold |
593
| – | – | 0.01% | 282 |
|
|
2024
Q3 | $59K | Hold |
593
| – | – | 0.01% | 285 |
|
|
2024
Q2 | $55K | Buy |
593
+138
| +30% | +$12.8K | 0.01% | 284 |
|
|
2024
Q1 | $43K | Hold |
455
| – | – | 0.01% | 294 |
|
|
2023
Q4 | $41K | Buy |
455
+53
| +13% | +$4.78K | 0.01% | 298 |
|
|
2023
Q3 | $29K | Buy |
402
+57
| +17% | +$4.11K | ﹤0.01% | 312 |
|
|
2023
Q2 | $29K | Buy |
345
+326
| +1,716% | +$27.4K | ﹤0.01% | 312 |
|
|
2023
Q1 | $7K | Sell |
19
-351
| -95% | -$129K | ﹤0.01% | 399 |
|
|
2022
Q4 | $31K | Buy |
370
+5
| +1% | +$419 | ﹤0.01% | 325 |
|
|
2022
Q3 | $29K | Sell |
365
-25
| -6% | -$1.99K | 0.01% | 333 |
|
|
2022
Q2 | $29K | Buy |
390
+60
| +18% | +$4.46K | ﹤0.01% | 338 |
|
|
2022
Q1 | $30K | Buy |
330
+40
| +14% | +$3.64K | ﹤0.01% | 343 |
|
|
2021
Q4 | $32K | Buy |
290
+15
| +5% | +$1.66K | ﹤0.01% | 353 |
|
|
2021
Q3 | $35K | Buy |
275
+10
| +4% | +$1.27K | 0.01% | 339 |
|
|
2021
Q2 | $36K | Buy |
265
+45
| +20% | +$6.11K | 0.01% | 351 |
|
|
2021
Q1 | $30K | Buy |
220
+130
| +144% | +$17.7K | ﹤0.01% | 345 |
|
|
2020
Q4 | $13K | Buy |
90
+20
| +29% | +$2.89K | ﹤0.01% | 388 |
|
|
2020
Q3 | $8K | Buy |
70
+40
| +133% | +$4.57K | ﹤0.01% | 385 |
|
|
2020
Q2 | $3K | Hold |
30
| – | – | ﹤0.01% | 448 |
|
|
2020
Q1 | $2K | Hold |
30
| – | – | ﹤0.01% | 459 |
|
|
2019
Q4 | $3K | Hold |
30
| – | – | ﹤0.01% | 432 |
|
|
2019
Q3 | $2K | Buy |
+30
| New | +$2K | ﹤0.01% | 486 |
|